• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 Hu-PBL 小鼠研究人类局限性病毒的发病机制。

Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses.

机构信息

Bernhard-Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.

German Center for Infection Research, Partner Site Hamburg-Borstel-Lübeck, 38124 Braunschweig, Germany.

出版信息

Viruses. 2023 Jan 13;15(1):228. doi: 10.3390/v15010228.

DOI:10.3390/v15010228
PMID:36680271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9866769/
Abstract

Different humanized mouse models have been developed to study human diseases such as autoimmune illnesses, cancer and viral infections. These models are based on the use of immunodeficient mouse strains that are transplanted with human tissues or human immune cells. Among the latter, mice transplanted with hematopoietic stem cells have been widely used to study human infectious diseases. However, mouse models built upon the transplantation of donor-specific mature immune cells are still under development, especially in the field of viral infections. These models can retain the unique immune memory of the donor, making them suitable for the study of correlates of protection upon natural infection or vaccination. Here, we will review some of these models and how they have been applied to virology research. Moreover, the future applications and the potential of these models to design therapies against human viral infections are discussed.

摘要

已经开发了不同的人源化小鼠模型来研究人类疾病,如自身免疫性疾病、癌症和病毒感染。这些模型基于使用免疫缺陷小鼠品系,这些小鼠品系移植了人类组织或人类免疫细胞。在后者中,移植了造血干细胞的小鼠被广泛用于研究人类传染病。然而,基于供体特异性成熟免疫细胞移植的小鼠模型仍在开发中,特别是在病毒感染领域。这些模型可以保留供体独特的免疫记忆,使其适合于研究自然感染或接种疫苗后的保护相关性。在这里,我们将回顾其中的一些模型,以及它们如何被应用于病毒学研究。此外,还讨论了这些模型的未来应用及其设计针对人类病毒感染的治疗方法的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/9866769/902194f9fefb/viruses-15-00228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/9866769/902194f9fefb/viruses-15-00228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b62/9866769/902194f9fefb/viruses-15-00228-g001.jpg

相似文献

1
Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses.利用 Hu-PBL 小鼠研究人类局限性病毒的发病机制。
Viruses. 2023 Jan 13;15(1):228. doi: 10.3390/v15010228.
2
Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.新型人外周血淋巴细胞免疫缺陷小鼠品系中的原发性人类免疫缺陷病毒1型病毒血症及中枢神经系统侵袭
J Virol. 1997 Mar;71(3):2417-24. doi: 10.1128/JVI.71.3.2417-2424.1997.
3
Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice.通过将SiHa细胞接种到人类化严重联合免疫缺陷小鼠中建立宫颈癌模型。
Eur J Gynaecol Oncol. 2006;27(6):566-72.
4
HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.在抑制性口服联合抗逆转录病毒疗法期间,人源化NSG小鼠模型中的HIV复制与潜伏
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.02118-17. Print 2018 Apr 1.
5
Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge.用编码1型人类免疫缺陷病毒(HIV-1)糖蛋白120的单纯疱疹病毒扩增子转导的人树突状细胞,可引发植入NOD/SCID小鼠体内的人细胞产生适应性免疫反应,并对HIV-1攻击提供部分保护。
J Virol. 2005 Feb;79(4):2124-32. doi: 10.1128/JVI.79.4.2124-2132.2005.
6
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies.用于HIV复制和潜伏性研究的人源化NOD/SCID/IL2rγnull(hu-NSG)小鼠模型
J Vis Exp. 2019 Jan 7(143). doi: 10.3791/58255.
7
Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.1型人类免疫缺陷病毒的R5和X4毒株在人外周血淋巴细胞-重症联合免疫缺陷(hu-PBL-SCID)小鼠中会引发不同的致病效应,这取决于初次感染时人类靶细胞的激活/分化状态。
J Virol. 1999 Aug;73(8):6453-9. doi: 10.1128/JVI.73.8.6453-6459.1999.
8
The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.人类HIV/外周血淋巴细胞(PBL)-重症联合免疫缺陷(SCID)小鼠。一种用于研究HIV发病机制和治疗的改良型人类PBL-SCID模型。
J Immunol. 1995 Jun 15;154(12):6612-23.
9
Human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL SCID) models of toxoplasmosis.弓形虫病的人外周血淋巴细胞重症联合免疫缺陷(hu-PBL SCID)模型。
Immunol Cell Biol. 2000 Dec;78(6):608-15. doi: 10.1046/j.1440-1711.2000.00957.x.
10
Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.利用 Hu-PBL-NSG 肺癌模型评估免疫肿瘤药物的有前景的临床前平台。
Lung Cancer. 2019 Jan;127:112-121. doi: 10.1016/j.lungcan.2018.11.035. Epub 2018 Nov 27.

引用本文的文献

1
Humanized Mouse Models of Bacterial Infections.细菌感染的人源化小鼠模型
Antibiotics (Basel). 2024 Jul 11;13(7):640. doi: 10.3390/antibiotics13070640.
2
Current Advances in Humanized Mouse Models for Studying NK Cells and HIV Infection.用于研究自然杀伤细胞和HIV感染的人源化小鼠模型的当前进展
Microorganisms. 2023 Aug 2;11(8):1984. doi: 10.3390/microorganisms11081984.
3
Challenges in development of vaccines directed toward antimicrobial resistant bacterial species.针对抗微生物药物耐药细菌的疫苗开发面临的挑战。

本文引用的文献

1
Hepatitis B and C viral coinfections and their association with HIV viral load suppression among HIV-1 infected patients on ART at Mekelle hospital, northern Ethiopia.在埃塞俄比亚北部梅开勒医院接受抗逆转录病毒治疗的 HIV-1 感染患者中,乙型和丙型肝炎病毒合并感染及其与 HIV 病毒载量抑制的关系。
AIDS Res Ther. 2022 Dec 1;19(1):57. doi: 10.1186/s12981-022-00479-8.
2
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2.mRNA 疫苗加强针增强了对 SARS-CoV-2 的 T 细胞和抗体反应的衰减。
Front Immunol. 2022 Oct 12;13:1012526. doi: 10.3389/fimmu.2022.1012526. eCollection 2022.
3
Immune correlates of protection following Rift Valley fever virus vaccination.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2228669. doi: 10.1080/21645515.2023.2228669.
裂谷热病毒疫苗接种后的保护性免疫相关因素。
NPJ Vaccines. 2022 Oct 28;7(1):129. doi: 10.1038/s41541-022-00551-4.
4
Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity.评估针对具有逃避免疫潜力的 COVID-19 VOC 的混合匹配疫苗的保护相关因素。
Vaccine. 2022 Nov 8;40(47):6864-6872. doi: 10.1016/j.vaccine.2022.10.011. Epub 2022 Oct 17.
5
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection.COVID-19 疫苗更新:疫苗效力、SARS-CoV-2 变体、加强针、不良反应以及保护的免疫相关性。
J Biomed Sci. 2022 Oct 15;29(1):82. doi: 10.1186/s12929-022-00853-8.
6
Generation of SARS-CoV-2 Mouse Model by Transient Expression of the Human Gene Mediated by Intranasal Administration of AAV-hACE2.通过鼻内给予AAV-hACE2介导的人基因瞬时表达产生SARS-CoV-2小鼠模型。
Mol Biol. 2022;56(5):705-712. doi: 10.1134/S0026893322050065. Epub 2022 Oct 5.
7
Murine Models of Chronic Viral Infections and Associated Cancers.慢性病毒感染及相关癌症的小鼠模型
Mol Biol. 2022;56(5):649-667. doi: 10.1134/S0026893322050028. Epub 2022 Oct 5.
8
SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season.SARS-CoV-2 和流感合并感染:2021-2022 年流感季美国密苏里州中部的一项横断面研究。
Virology. 2022 Nov;576:105-110. doi: 10.1016/j.virol.2022.09.009. Epub 2022 Sep 30.
9
Nanovaccines to combat virus-related diseases.用于对抗病毒相关疾病的纳米疫苗。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Mar;15(2):e1857. doi: 10.1002/wnan.1857. Epub 2022 Oct 2.
10
Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.共感染与癌症:树突状细胞与 HIV-1、HTLV-1 和其他致癌病毒之间的宿主-病原体相互作用。
Viruses. 2022 Sep 14;14(9):2037. doi: 10.3390/v14092037.